Recently, Pfizer also successfully secured the ownership of GLP-1 biotechnology company Metsera after a surprise bidding conflict, adding Metseras injectable asset, MET-097i (which is in Phase 2b testing and has the potential for once-a-month dosing), to its portfolio
Biochemistry Moscow 89: 18681888
Estamos ante una nueva generacin de frmacos (Ozempic, Wegovy, Mounjaro, etc.) que podran transformar la manera en que tratamos no solo la diabetes, sino tambin algunas de las enfermedades crnicas ms prevalentes de nuestros das
such effects of DPP-4 inhibition on autophagy signaling were completely abolished by GLP-1R antagonist exendin 9-39 coadministration (Liu et al., 2016)
In addition, eating sufficient protein (0.8-1.5 g/kg of body weight per day, the higher range being for older adults) is critical to prevent the muscle loss that can occur with GLP-1 treatment